← Leaderboards
Herbert H Seltzman
Artiam Bio Inc.
$945,046
Attributed
$945,046
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $368.7K · FY2021–23$500K$375K$250K$125K$0
'21
'22
'23
Funding mix
By agency
NIH$945,046 · 3
By mechanism
R41$625,148 · 2
R43$319,898 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Rodent”
- Xinhua Li · Nano Terra, Inc.$23,903,965
- Rui M. Costa · Columbia University Health Sciences$13,762,381
- Nanthia A Suthana · University Of California Los Angeles$12,058,212
- Karen Marie Dobos · Colorado State University$11,585,271
- Anna Upton · Global Alliance For Tb Drug Development$10,496,979
- Jay Evans · University Of Montana$9,566,206
Research focus
RodentPharmaceutical PreparationsNovel TherapeuticsRimonabantRattusAgonistDoseLead CandidatePropertyReceptorEmotionalCnr1 GeneAmericanAnhedoniaAdverse EffectsBehavioralGenerationsLeadDesignDysphoriaBaseAddictionEfficacy StudyClinical Development